IL6 and breast carcinoma: In conclusion, this study reveals a novel function for EphA2 signaling in tumor cell–bone cell interactions involved in osteoclastogenesis and osteolysis associated with breast cancer metastasis, in part through regulation of cytokines such as IL‐6.